Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $42.3900 (-1.44%) ($41.4600 - $42.3900) on Mon. May. 17, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.97% (three month average) | RSI | 11 | Latest Price | $42.3900(-1.44%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -1.9% a day on average for past five trading days. | Weekly Trend | HALO declines -8.3% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(50%) IWO(49%) IWM(47%) IWC(44%) IWN(43%) | Factors Impacting HALO price | HALO will decline at least -1.485% in a week (0% probabilities). VIXM(-31%) VXX(-12%) UUP(-11%) GLD(-1%) TLT(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.485% (StdDev 2.97%) | Hourly BBV | -0.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $31.53(-25.62%) | Resistance Level | $47.3 | 5 Day Moving Average | $42.48(-0.21%) | 10 Day Moving Average | $44.88(-5.55%) | 20 Day Moving Average | $47.3(-10.38%) | To recent high | -18.4% | To recent low | 7.1% | Market Cap | $5.794b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |